ASCENTAGE PHARMA GROUP INTERNATIONAL

Contributing Author

Recent Articles by ASCENTAGE PHARMA GROUP INTERNATIONAL

Jun-09	Thirteen Studies of Ascentage Pharma's Assets Including Olverembatinib and Lisaftoclax Selected for Presentations at 2025 European Hematology Association Annual Congress AAPG GlobeNewswire
Jun-02	Live from ASCO 2025 Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report AAPG GlobeNewswire
Jun-02	Live from ASCO 2025 Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors AAPG GlobeNewswire
May-22	Ascentage Pharma Announces Clinical Data of Lisaftoclax, Which Shows Therapeutic Potential in Venetoclax-Refractory Patients, Selected for Oral Report at ASCO 2025 AAPG GlobeNewswire